[TNF inhibitors and myelitis: think about it, even lately].
Anti-TNF medications have been widely used for the treatment of auto-immune disease and new drugs are regularly approved. We report here a case of late myelitis after more than 6 years of adalimumab in a 74-year-old woman treated for rheumatoid polyarthritis.